Publication | Closed Access
Quantitative assessment of sustained‐release 4‐aminopyridine for symptomatic treatment of multiple sclerosis
190
Citations
0
References
1997
Year
4AP SR improved motor function in MS patients. The quantitative outcomes used in this study permit more sensitive evaluation of the therapeutic effect and promise to be useful in future trials of symptomatic treatments for MS.